EssilorLuxottica (EL.PA) receives Old York Operational Quality (A) Rating for fiscal year 2025

Mar 1

(A) | Consumer Discretionary | Luxury
By: Old York Financial
A Private Principal Research Report

the verdict

Old York Financial has assigned EssilorLuxottica (EL.PA) an Operational Quality (A) Rating. Luxottica is a "Mandatory Monopoly", if you need to see, you likely pay them a toll. In 2025, the company achieved a historic milestone with €28.49 Billion in revenue (+11.2% at constant exchange), driven by the explosive success of the Ray-Ban Meta AI glasses (7M+ units sold). It earns an (A) for its iron-clad grip on the global optical supply chain. However, it remains below the (AA) tier due to "Integration Friction." Despite its dominance, the company operates with a 15.7% adjusted operating margin, healthy but a far cry from the 30-40% "Purity" of our (AAA) luxury sovereigns. For the Principal, Luxottica is a high-volume, tech-heavy infrastructure play on the world's aging eyesight.

the old york analysis

owner earnings: the vision tax We evaluate Luxottica’s ability to turn a lens monopoly into hard cash. The business is capital-intensive due to its massive retail footprint and manufacturing lab network.

2025 Operating Cash Flow: €5.91 Billion
(-) Capital Expenditures: (€1.65 Billion)
(+) Depreciation & Amortization: €3.11 Billion
OLD YORK OWNER EARNINGS: €7.37 Billion

Analyst Note: Luxottica’s "Secret Weapon" is its negative working capital in retail and its massive depreciation shield. While Net Profit was €2.32B, the Owner Earnings of €7.37B reveal a much more powerful cash-generative machine than the surface-level IFRS earnings suggest.

operational efficiency

ROIC (Return on Invested Capital): 6.8%
ROE (Return on Equity): 5.9%
Net Profit Margin: 8.1% *
Adjusted Operating Margin: 15.7% (Impacted by US tariffs and AI-glass R&D).
Direct-to-Consumer Growth: +10.2% (The retail engine is firing on all cylinders).
Analyst Note (The Efficiency Gap): The 6.8% ROIC is the "Clogged Pipe." Luxottica has spent billions on acquisitions (GrandVision, Supreme, etc.). This has bloated the balance sheet with goodwill and tangible assets, diluting the return on every Euro invested. It is a "Wide-Moat" business, but an "Asset-Heavy" one.

growth & market dominance

2025 Consolidated Revenue: €28.49 Billion.
The AI Pivot: Ray-Ban Meta glasses sold over 7 million units in 2025. Luxottica is successfully transitioning from a "Frame Maker" to a "Wearable Tech" leader.
Myopia Management: Revenues grew +22%, securing the future "Toll" for the next generation of eyeglass wearers.
Regional Dominance: North America and EMEA both grew double digits, proving that even in a volatile economy, "Vision" is a non-discretionary expense.

the fortress check

Net Debt: €10.85 Billion (Including €3.56B in lease liabilities).
Total Shareholder Equity: €39.5 Billion.
Net Debt/EBITDA: ~1.6x (Very manageable).
Capital Allocation: Proposed dividend of €4.00 per share. Luxottica is a steady "Yield Machine" for the long-term Principal.
Liquidity: Strong, with €3.54 Billion in cash and equivalents to fund its "MedTech" transformation.

final determination

Rating: Old York Quality (A)

Classification: The Global Optical Toll Bridge.

Luxottica is an (A) because of its absolute dominance and the "Inelastic Demand" for its products. It is prevented from moving to (AA) by its low 6.8% ROIC and the high capital intensity required to maintain its global retail empire. It is a defensive powerhouse, not a high-efficiency sprinter.

Disclaimer: Old York Financial operates privately as a principal and sells corporate advisory. Old York Financial is not an accountant, a financial advisor, a broker, an agent, a lawyer, or a portfolio manager. This report is for informational purposes only.

Old York GP inc .